Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

4
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
4
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

4
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
4
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

3
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

203
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
203
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

3
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term effectiveness and overdiagnosis in the NHS breast screening programme: a cohort study with up to 33 years of follow-up.

British journal of cancer·2026
Same author

Colorectal cancer screening: An update to the American Cancer Society guideline, 2026.

CA: a cancer journal for clinicians·2026
Same author

The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancer.

Cancer·2026
Same author

Colorectal cancer statistics, 2026.

CA: a cancer journal for clinicians·2026
Same author

Diagnostic Follow-up of Positive Results on Low-Dose Computed Tomography Screening in the Medicare Population.

Annals of internal medicine·2025
Same author

Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline.

CA: a cancer journal for clinicians·2025
Same journal

Phytochemicals remodel antitumor immunity via the "microbiota-metabolite-receptor" axis: focus on colorectal cancer and immunotherapy.

Medical oncology (Northwood, London, England)·2026
Same journal

Combinatorial cancer therapy mediated by hydroxyapatite nanoparticles: a comprehensive review.

Medical oncology (Northwood, London, England)·2026
Same journal

IFITM3 promotes an M2-like tumor-supportive microenvironment in acute myeloid leukemia.

Medical oncology (Northwood, London, England)·2026
Same journal

Liposomal honokiol attenuates dimethylhydrazine-induced colon carcinogenesis in rats through modulation of oxidative stress, inflammation, apoptosis, autophagy, and lipid metabolism pathways.

Medical oncology (Northwood, London, England)·2026
Same journal

Identification of a lncRNA prognostic signature reveals that SNAI3-AS1 cooperates with erastin to reshape macrophage polarization in glioma.

Medical oncology (Northwood, London, England)·2026
Same journal

Effects of Astragalus membranaceus injection at Zusanli (ST36) acupoint on lung cancer with COPD.

Medical oncology (Northwood, London, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

8.0K

Progress in lymphedema.

Robert A Smith1

  • 1American Cancer Society Center for Early Cancer Detection Science, American Cancer Society, Atlanta, GA, USA. robert.smith@cancer.org.

Medical Oncology (Northwood, London, England)
|October 8, 2024
PubMed
Summary
This summary is machine-generated.

Secondary lymphedema after mastectomy has been recognized for a century, with significant research and consensus-building efforts emerging since the late 1990s. The 2023 Lymphedema Summit highlights progress in understanding and managing this condition.

Keywords:
ConsensusLymphedemaPrevalenceRisk reductionSurveillance

More Related Videos

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
05:44

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

10.0K
A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

5.6K

Related Experiment Videos

Last Updated: Jun 11, 2025

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

8.0K
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
05:44

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

10.0K
A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

5.6K

Area of Science:

  • Oncology
  • Lymphedema Research
  • Cancer Rehabilitation

Background:

  • Secondary lymphedema following mastectomy has been documented for over 100 years.
  • Early research focused on causes and clinical observations, with limited understanding of risks and patient education.
  • Significant knowledge gaps persisted regarding lymphedema prevalence, onset risks, and standardized treatment until the late 1990s.

Discussion:

  • The American Cancer Society initiated a sustained commitment in 1998 to address lymphedema challenges.
  • Key initiatives included international workshops, research funding, and supporting the Lymphology Association of North America (LANA).
  • Progress has been made in developing models for rehabilitation, such as the prospective surveillance model for breast cancer patients.

Key Insights:

  • The 2023 Lymphedema Summit convened experts to discuss advancements and future directions in lymphedema management.
  • The summit aimed to consolidate current knowledge and establish consensus on best practices.
  • Focus areas included understanding predisposing risks, prevalence, and effective patient education strategies.

Outlook:

  • Continued research and collaboration are crucial for improving lymphedema care.
  • The development of standardized treatment protocols and quality assurance measures remains a priority.
  • Future efforts will likely focus on prospective surveillance and innovative management techniques for lymphedema.